Cargando…
Targeting eIF3f Suppresses the Growth of Prostate Cancer Cells by Inhibiting Akt Signaling
BACKGROUND: Eukaryotic initiation factor 3 (eIF3) is the largest translation initiation factor, and oncogenic roles have been discovered for its subunits, including the f subunit (ie, eIF3f), in various human cancers. However, the roles of eIF3f in the development and progression of prostate cancer...
Autores principales: | Li, Junhong, Yu, Wandong, Ge, Jianchao, Zhang, Jun, Wang, Yang, Wang, Pengyu, Shi, Guowei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210466/ https://www.ncbi.nlm.nih.gov/pubmed/32440143 http://dx.doi.org/10.2147/OTT.S244345 |
Ejemplares similares
-
DDX52 knockdown inhibits the growth of prostate cancer cells by regulating c-Myc signaling
por: Yu, Wandong, et al.
Publicado: (2021) -
Transcription factor KLF13 inhibits AKT activation and suppresses the growth of prostate carcinoma cells
por: Wang, Qiang, et al.
Publicado: (2018) -
USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-Myc
por: Ge, Jianchao, et al.
Publicado: (2021) -
Solamargine Inhibits Prostate Cancer Cell Growth and Enhances the Therapeutic Efficacy of Docetaxel via Akt Signaling
por: Ge, Jianchao, et al.
Publicado: (2022) -
Identification of molecular subtypes and a prognostic signature based on chromatin regulators related genes in prostate cancer
por: Ma, Hangbin, et al.
Publicado: (2023)